Availability of Analgesic and Anti-Inflammatory Medicines in Primary Health Care
Keywords:
Primary Health Care, Pharmaceutical Services, Drugs, EssentialAbstract
Objective: To describe and analyze the availability and factors related to the presence of analgesics and non-steroidal anti-inflammatory drugs in the Brazilian public primary healthcare system. Material and Methods: This was a cross-sectional study that evaluated 17,903 health units that participated in the National Program for Primary Care Access and Quality Improvement (2013-2014). The dependent variable was defined as the presence of metamizole, ibuprofen, and acetaminophen in a sufficient amount. The independent variables included the type of primary health care unit, the presence of a medication disposal area, the number of physicians, nurses, and dental practitioners; and the number of primary care units with family and oral health teams. For statistical analysis, unadjusted and adjusted Odds Ratio (OR) (95% CI) were presented. Results: The three medicines were available in 62.4% of the units. Regarding Health Clinics, the Basic Health Units (OR= 1.31, CI95% 1.18-1.44), Polyclinic (OR= 2.00, 95% CI, 1.15 -3.48), and others (OR= 1.37; 95% CI 1.14-1.63) had higher chances of availability of all three drugs. The presence of a disposal area (OR = 1.64, 95% CI 1.51-1.77) and the number of physicians (OR= 1.04, 95% CI 1.00-1.08), nurses (OR= 1.08, 95% CI 1.03- 1.13), and dental practitioners (OR= 1.09, 95% CI 1.04-1.14) increased the availability odds of the analyzed drugs in the service. Conclusion: The structure of the healthcare units and the higher number of professionals were positively associated with the availability of these drugs.
References
Collaborators Global Burden of Disease (GBD). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386(9995):743-800. https://doi.org/10.1016/S0140-6736(15)60692-4
Strand EB, Mengshoel AM, Sandvik L, Helland IB, Abraham S, Nes LS. Pain is associated with reduced quality of life and functional status in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Scand J Pain 2019; 19(1):61-72. https://doi.org/10.1515/sjpain-2018-0095
Husky MM, Ferdous Farin F, Compagnone P, Fermanian C, Kovess-Masfety V. Chronic back pain and its association with quality of life in a large French population survey. Health Qual Life Outcomes 2018; 16(1):195. https://doi.org/10.1186/s12955-018-1018-4
de Souza JB, Grossmann E, Perissinotti DMN, de Oliveira Junior JO, da Fonseca PRB, Posso IP. Prevalence of chronic pain, treatments, perception, and interference on life activities: Brazilian population-based survey. Pain Res Manag 2017; 2017:4643830. https://doi.org/10.1155/2017/4643830
Vuilleumier PH, Schliessbach J, Curatolo M. Current evidence for central analgesic effects of NSAIDs: an overview of the literature. Minerva Anestesiol 2018; 84(7):865-70. https://doi.org/10.23736/S0375-9393.18.12607-1
Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res 2015; 8:105-18. https://doi.org/10.2147/JPR.S75160
Al-Shidhani A, Al-Rawahi N, Al-Rawahi A, P SM. Non-steroidal anti-inflammatory drugs (NSAIDs) use in primary health care centers in A'Seeb, Muscat: a clinical audit. Oman Med J 2015; 30(5):366-71. https://doi.org/10.5001/omj.2015.73
World Health Organization. 21st WHO Model List of Essential Medicines. Available from: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1. [Accessed on February 23, 2020].
da Silva Dal Pizzol T, Turmina Fontanella A, Cardoso Ferreira MB, Dâmaso Bertoldi A, Boff Borges R, Serrate Mengue S. Analgesic use among the Brazilian population: results from the national survey on access, use and promotion of rational use of medicines (PNAUM). PLoS One 2019; 14(3):e0214329. https://doi.org/10.1371/journal.pone.0214329
Costa CMFN, Silveira MR, Acurcio FA, Guerra AA, Guibu IA, Costa KS, et al. Use of medicines by patients of the primary health care of the Brazilian Unified Health System. Rev Saúde Pública 2017; 51(suppl 2):18s. https://doi.org/10.11606/S1518-8787.2017051007144
Brasil. Lei nº 8.080, de 19 de setembro de 1990. Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providências. Brasília: Diário Oficial da União. Section 1:018055. [In Portuguese].
Brasil. Ministério da Saúde. Portaria nº 3.916, de 30 de outubro de 1998. Aprova a Política Nacional de Medicamentos e dá outras providências. Brasília: Diário Oficial União; 1998 Oct. 30. Section 1:18. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/1998/prt3916_30_10_1998.html. [Accessed on February 23, 2020]. [In Portuguese].
Brasil. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n. 338, de 06 de maio de 2004. Aprova a Política Nacional de Assistência Farmacêutica [Internet]. Brasília: Diário Oficial União; 2004 May 06. Section 1:52. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/cns/2004/res0338_06_05_2004.html. [Accessed on February 23, 2020]. [In Portuguese].
Brasil. Ministério da Saúde. Programa Nacional de Melhoria do Acesso e da Qualidade da Atenção Básica (PMAQ- AB): Manual Instrutivo [Internet]. Brasília: Ministério da Saúde; 2015. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/manual_instrutivo_pmaq_atencao_basica.pdf. [Accessed on February 23, 2020]. [In Portuguese].
Brasil. Programa Nacional de Melhoria do Acesso e da Qualidade da Atenção Básica (PMAQ). Brasília: Ministério da Saúde Available from: http://aps.saude.gov.br/ape/pmaq. [Accessed on February 23, 2020]. [In Portuguese].
Souza MF, Santos AFD, Reis IA, Santos MADC, Jorge AO, Machado ATGD, et al. Care coordination in PMAQ-AB: An Item Response Theory-based analysis. Rev Saúde Pública 2017; 51:87. https://doi.org/10.11606/S1518-8787.2017051007024
World Health Organization. Equitable access to essential medicines: a framework for collective action. Available from: http://apps.who.int/iris/bitstream/handle/10665/68571/WHO_EDM_2004.4_eng.pdf?sequence=1&is Allowed=y. [Accessed on February 23, 2020]. [In Portuguese].
Mendes LV, Campos MR, Chaves GC, Silva RMd, Freitas PdS, Costa KS, et al. Availability of medicines in primary health care facilities and related factors: a cross sectional approach. Saúde Debate 2014; 38(spe):109-23. https://doi.org/10.5935/0103-1104.2014S009
Nascimento RCRM, Álvares J, Guerra AA, Gomes IC, Costa EA, Leite SN, et al. Availability of essential medicines in primary health care of the Brazilian Unified Health System. Rev Saúde Pública. 2017; 51(suppl 2):10s. https://doi.org/10.11606/s1518-8787.2017051007062
Barros RD, Costa EA, Santos DBD, Souza GS, Álvares J, Guerra AA, et al. Access to medicines: relations with the institutionalization of pharmaceutical services. Rev Saúde Pública. 2017; 51(suppl 2):8s. https://doi.org/10.11606/S1518-8787.2017051007138
Paniz VMV, Cechin ICCF, Fassa AG, Piccini RX, Tomasi E, Thumé E, et al. Access to medicines prescribed for acute health conditions in adults in South and Northeast Brazil. Cad Saúde Pública 2016; 32(4):e00009915-e. https://doi.org/10.1590/0102-311X00009915
Brasil. Ministério da Saúde. Brasília: Programa de Melhoria do Acesso e da Qualidade – 2º ciclo. Available from: http://aps.saude.gov.br/ape/pmaq/ciclo2/. [Accessed on August 20, 2019]. [In Portuguese].
Brasil. Ministério da Saúde. Secretaria de Assistência à Saúde. Portaria nº 511 de 29 de dezembro de 2000. Aprova a Ficha Cadastral dos Estabelecimentos de Saúde – FCES, o Manual de Preenchimento e a planilha de dados profissionais constantes no Anexo I, Anexo II, Anexo III, desta Portaria, bem como a criação do Banco de Dados Nacional de Estabelecimentos de Saúde. Brasília: Ministério da Saúde; 2001. Available from: https://www.cremers.org.br/pdf/pj/PORT_SAS_511_2000.pdf. [Accessed on February 24, 2020]. [In Portuguese].
Boing AC, Bertoldi AD, Boing AF, Bastos JL, Peres KG. Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System. Cad Saúde Pública 2013; 29(4):691-701. https://doi.org/10.1590/S0102-311X2013000400007
Yamauti SM, Barberato-Filho S, Lopes LC. The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy. Cad Saúde Pública 2015; 31:1648-62. https://doi.org/10.1590/0102-311X00054814
Sparks JA. Rheumatoid arthritis. Ann Intern Med 2019; 170(1):ITC1-ITC16. https://doi.org/10.7326/AITC201901010
Enthoven WTM, Roelofs PD, Koes BW. NSAIDs for chronic low back pain. JAMA 2017; 317(22):2327-8. https://doi.org/10.1001/jama.2017.4571
Pereira GM, Cota LO, Lima RP, Costa FO. Effect of preemptive analgesia with ibuprofen in the control of postoperative pain in dental implant surgeries: a randomized, triple-blind controlled clinical trial. J Clin Exp Dent 2020; 12(1): e71-e8. https://doi.org/10.4317/jced.56171
World Health Organization. Addressing the global shortage of, and access to, medicines and vaccines. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB142/B142_13-en.pdf. [Accessed on February 23, 2020]. [In Portuguese].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Pesquisa Brasileira em Odontopediatria e Clínica Integrada
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
